AnnaWaldMD

Professor, Medicine, Laboratory Medicine & Pathology, Epidemiology University of Washington School of Medicine, Vaccine & Infectious Diseases Division, Fred Hutch

Join to view full profile

Dr. Wald is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wald's full profile

Already have an account?

Office
325 9th Ave
Seattle, WA 98122
Phone+1 206-520-4340
Is this information wrong?

Summary

Academic infectious diseases

Education & Training

University of WashingtonFellowship, Infectious Disease, 1991 - 1994
Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
Icahn School of Medicine at Mount SinaiClass of 1985

Certifications & Licensure

WA State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes Start of enrollment: 2005 Apr 01
Completed
Phase 3
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons Start of enrollment: 2003 Mar 01
Completed
Phase 4
A Study of HSV Testing Among Pregnant Women Start of enrollment: 2004 Jan 01
Terminated
Not Applicable
Suppression of Oral HHV8 Shedding With Valganciclovir Start of enrollment: 2002 Dec 01
Completed
Phase 2
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission Start of enrollment: 2004 Nov 01
Completed
Phase 3
HSV-2 Shedding Resolution After Acyclovir Treatment Start of enrollment: 2007 Jun 01
Completed
Effect of HSV-2 Suppressive Therapy on Sexual Behavior Start of enrollment: 2008 Jan 01
Terminated
Phase 4
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV Start of enrollment: 2007 Dec 01
Completed
Phase 4
GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women Start of enrollment: 2009 Jan 01
Completed
Not Applicable
An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons Start of enrollment: 2010 Jan 01
Withdrawn
Not Applicable
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding Start of enrollment: 2012 Feb 01
Completed
Phase 4
Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults Start of enrollment: 2013 Dec 01
Completed
Phase 1, Phase 2
Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Start of enrollment: 2014 Jul 01
Completed
Phase 2
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Start of enrollment: 2017 Aug 01
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

78 citations
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na...
Sharon E. Frey, Anna Wald, Srilatha Edupuganti, Lisa A. Jackson, Jack T. Stapleton
Vaccine. 2015-09-22
353 citations
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe, Peter A. Leone, David I. Bernstein, Anna Wald, Myron J. Levin
The New England Journal of Medicine. 2012-01-05
412 citations
Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons
Anna Wald, Judith Zeh, Stacy Selke, Terri Warren, Alexander J. Ryncarz
The New England Journal of Medicine. 2000-03-23

Other

6 Years Later, 9-Valent HPV Vaccine's Efficacy Persists
Anna Wald, MD, NEJM Journal Watch
https://www.doximity.com/articles/cdff9ad2-4105-4bf4-824f-237e6f302064
UpToDate, Wolters Kluwer Health - 2012-12-13
USPSTF Reinforces Recommendation for Syphilis Screening During Pregnancy
Wald A, Johnston C, NEJM Journal Watch
https://www.doximity.com/articles/09e15156-a346-4f86-81fe-97c28e40864b
UpToDate, Wolters Kluwer Health - 2012-06-29
STI Rates Climb for Fourth Straight Year
Wald A, Johnston C, NEJM Journal Watch
https://www.doximity.com/articles/b89f1dc2-5b06-4539-8d24-ab0e840c0258
UpToDate, Wolters Kluwer Health - 2012-03-01
Quantifying Pregnancy Outcomes in Zika-Infected Women
Anna Wald, MD, NEJM Journal Watch
https://www.doximity.com/articles/298779f5-faa0-4b80-ac98-695bf4651a55
UpToDate, Wolters Kluwer Health - 2012-02-17
Join now to see all

Authored Content

Quantifying Pregnancy Outcomes in Zika-Infected WomenNovember 2018
STI Rates Climb for Fourth Straight YearSeptember 2018
USPSTF Reinforces Recommendation for Syphilis Screening During PregnancySeptember 2018
6 Years Later, 9-Valent HPV Vaccine's Efficacy PersistsSeptember 2017
Join now to see all

Press Mentions

No Evidence of Justin Bieber’s Facial Paralysis Caused by COVID-19 VaccineJune 15th, 2022
No Evidence Justin Bieber’s Facial Paralysis Caused by COVID-19 VaccineJune 14th, 2022
2nd-Generation COVID-19 Vaccine Trial Seeks VolunteersMarch 30th, 2022
Join now to see all